vs
Side-by-side financial comparison of Life Time Group Holdings, Inc. (LTH) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Life Time Group Holdings, Inc. is the larger business by last-quarter revenue ($788.7M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Life Time Group Holdings, Inc. runs the higher net margin — 11.2% vs 6.8%, a 4.3% gap on every dollar of revenue. On growth, Life Time Group Holdings, Inc. posted the faster year-over-year revenue change (11.7% vs -1.7%). Over the past eight quarters, Life Time Group Holdings, Inc.'s revenue compounded faster (8.7% CAGR vs -0.1%).
Life Time Group Holdings, Inc. operates a network of premium athletic, fitness and wellness destinations across the United States. It offers diverse services including state-of-the-art gym facilities, group exercise classes, personal training, spa treatments, nutrition coaching, youth programs and co-working spaces for consumers pursuing holistic healthy lifestyles.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
LTH vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $788.7M | $493.8M |
| Net Profit | $88.1M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 17.1% | 9.9% |
| Net Margin | 11.2% | 6.8% |
| Revenue YoY | 11.7% | -1.7% |
| Net Profit YoY | 15.8% | 10.5% |
| EPS (diluted) | $0.39 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $788.7M | — | ||
| Q4 25 | $745.1M | $493.8M | ||
| Q3 25 | $782.6M | $492.9M | ||
| Q2 25 | $761.5M | $468.8M | ||
| Q1 25 | $706.0M | $458.4M | ||
| Q4 24 | $663.3M | $502.4M | ||
| Q3 24 | $693.2M | $511.2M | ||
| Q2 24 | $667.8M | $504.3M |
| Q1 26 | $88.1M | — | ||
| Q4 25 | $123.0M | $33.7M | ||
| Q3 25 | $102.4M | $71.7M | ||
| Q2 25 | $72.1M | $39.3M | ||
| Q1 25 | $76.1M | $20.7M | ||
| Q4 24 | $37.2M | $30.5M | ||
| Q3 24 | $41.4M | $19.4M | ||
| Q2 24 | $52.8M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | 49.1% | — | ||
| Q3 25 | 47.1% | — | ||
| Q2 25 | 47.0% | — | ||
| Q1 25 | 47.5% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | 46.5% | — | ||
| Q2 24 | 46.8% | — |
| Q1 26 | 17.1% | — | ||
| Q4 25 | 17.4% | 9.9% | ||
| Q3 25 | 17.3% | 13.8% | ||
| Q2 25 | 14.2% | 12.8% | ||
| Q1 25 | 15.2% | 7.0% | ||
| Q4 24 | 13.1% | 7.8% | ||
| Q3 24 | 13.5% | 6.6% | ||
| Q2 24 | 15.7% | -31.3% |
| Q1 26 | 11.2% | — | ||
| Q4 25 | 16.5% | 6.8% | ||
| Q3 25 | 13.1% | 14.5% | ||
| Q2 25 | 9.5% | 8.4% | ||
| Q1 25 | 10.8% | 4.5% | ||
| Q4 24 | 5.6% | 6.1% | ||
| Q3 24 | 6.0% | 3.8% | ||
| Q2 24 | 7.9% | -30.3% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.55 | $0.40 | ||
| Q3 25 | $0.45 | $0.84 | ||
| Q2 25 | $0.32 | $0.46 | ||
| Q1 25 | $0.34 | $0.24 | ||
| Q4 24 | $0.17 | $0.37 | ||
| Q3 24 | $0.19 | $0.23 | ||
| Q2 24 | $0.26 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | $375.2M |
| Total DebtLower is stronger | $1.5B | $570.5M |
| Stockholders' EquityBook value | $3.2B | $865.9M |
| Total Assets | $8.1B | $2.2B |
| Debt / EquityLower = less leverage | 0.46× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $120.0M | — | ||
| Q4 25 | $204.8M | $375.2M | ||
| Q3 25 | $218.9M | $340.1M | ||
| Q2 25 | $175.5M | $224.7M | ||
| Q1 25 | $59.0M | $99.0M | ||
| Q4 24 | $10.9M | $229.9M | ||
| Q3 24 | $120.9M | $103.8M | ||
| Q2 24 | $34.5M | $19.4M |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $570.5M | ||
| Q3 25 | $1.5B | $577.2M | ||
| Q2 25 | $1.5B | $583.9M | ||
| Q1 25 | $1.5B | $590.5M | ||
| Q4 24 | $1.5B | $597.1M | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.1B | $865.9M | ||
| Q3 25 | $3.0B | $890.7M | ||
| Q2 25 | $2.9B | $833.8M | ||
| Q1 25 | $2.7B | $789.2M | ||
| Q4 24 | $2.6B | $764.9M | ||
| Q3 24 | $2.6B | $732.5M | ||
| Q2 24 | $2.4B | $706.5M |
| Q1 26 | $8.1B | — | ||
| Q4 25 | $8.0B | $2.2B | ||
| Q3 25 | $7.8B | $2.2B | ||
| Q2 25 | $7.6B | $2.1B | ||
| Q1 25 | $7.3B | $2.0B | ||
| Q4 24 | $7.2B | $2.2B | ||
| Q3 24 | $7.2B | $2.1B | ||
| Q2 24 | $7.1B | $2.0B |
| Q1 26 | 0.46× | — | ||
| Q4 25 | 0.48× | 0.66× | ||
| Q3 25 | 0.51× | 0.65× | ||
| Q2 25 | 0.53× | 0.70× | ||
| Q1 25 | 0.56× | 0.75× | ||
| Q4 24 | 0.59× | 0.78× | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $198.8M | $114.1M |
| Free Cash FlowOCF − Capex | $-61.2M | — |
| FCF MarginFCF / Revenue | -7.8% | — |
| Capex IntensityCapex / Revenue | 26.0% | — |
| Cash ConversionOCF / Net Profit | 2.26× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-123.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $198.8M | — | ||
| Q4 25 | $239.9M | $114.1M | ||
| Q3 25 | $251.1M | $137.3M | ||
| Q2 25 | $195.7M | $137.2M | ||
| Q1 25 | $183.9M | $-117.5M | ||
| Q4 24 | $163.1M | $133.0M | ||
| Q3 24 | $151.1M | $91.8M | ||
| Q2 24 | $170.4M | $107.0M |
| Q1 26 | $-61.2M | — | ||
| Q4 25 | $-64.6M | — | ||
| Q3 25 | $28.6M | — | ||
| Q2 25 | $-26.3M | — | ||
| Q1 25 | $41.4M | — | ||
| Q4 24 | $26.8M | — | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $26.1M | — |
| Q1 26 | -7.8% | — | ||
| Q4 25 | -8.7% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | -3.5% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 3.9% | — |
| Q1 26 | 26.0% | — | ||
| Q4 25 | 40.9% | — | ||
| Q3 25 | 28.4% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 20.2% | — | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 21.6% | — |
| Q1 26 | 2.26× | — | ||
| Q4 25 | 1.95× | 3.39× | ||
| Q3 25 | 2.45× | 1.91× | ||
| Q2 25 | 2.71× | 3.49× | ||
| Q1 25 | 2.41× | -5.66× | ||
| Q4 24 | 4.39× | 4.36× | ||
| Q3 24 | 3.65× | 4.72× | ||
| Q2 24 | 3.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LTH
| Center revenue | $767.6M | 97% |
| Other revenue | $21.1M | 3% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
